Author: Matsuhisa, Fumikazu; Kitajima, Shuji; Nishijima, Kazutoshi; Akiyoshi, Toshiaki; Morimoto, Masatoshi; Fan, Jianglin. 2020.
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Transgenic rabbits have contributed to the progress of biomedical science as human disease models because of their unique features, such as the lipid metabolism system similar to humans and medium body size that facilitates handling and experimental manipulation. In fact, many useful transgenic rabbits have been generated and used in research fields such as lipid metabolism and atherosclerosis, cardiac failure, immunology, and oncogenesis. However, there have been long-term problems, namely that the transgenic efficiency when using pronuclear microinjection is low compared with transgenic mice and production of knockout rabbits is impossible owing to the lack of embryonic stem cells for gene targeting in rabbits. Despite these limitations, the emergence of novel genome editing technology has changed the production of genetically modified animals including the rabbit. We are finally able to produce both transgenic and knockout rabbit models to analyze gain- and loss-of-functions of specific genes. It is expected that the use of genetically modified rabbits will extend to various research fields. In this review, we describe the unique features of rabbits as laboratory animals, the current status of their development and use, and future perspectives of transgenic rabbit models for human diseases.Cite this article
Matsuhisa F, Kitajima S, Nishijima K, Akiyoshi T, Morimoto M, Fan J. Transgenic Rabbit Models: Now and the Future. Applied Sciences. 2020; 10(21):7416.https://doi.org/10.3390/app10217416 